Logo image of SNBR

SLEEP NUMBER CORP (SNBR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SNBR - US83125X1037 - Common Stock

8.42 USD
-0.04 (-0.47%)
Last: 12/18/2025, 8:00:02 PM
8.28 USD
-0.14 (-1.66%)
After Hours: 12/18/2025, 8:00:02 PM
Fundamental Rating

1

Taking everything into account, SNBR scores 1 out of 10 in our fundamental rating. SNBR was compared to 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of SNBR have multiple concerns. SNBR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year SNBR has reported negative net income.
SNBR had a negative operating cash flow in the past year.
In multiple years SNBR reported negative net income over the last 5 years.
Of the past 5 years SNBR 4 years had a positive operating cash flow.
SNBR Yearly Net Income VS EBIT VS OCF VS FCFSNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

The Return On Assets of SNBR (-10.42%) is worse than 74.59% of its industry peers.
SNBR's Return On Invested Capital of 3.59% is in line compared to the rest of the industry. SNBR outperforms 50.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SNBR is below the industry average of 12.16%.
The last Return On Invested Capital (3.59%) for SNBR is well below the 3 year average (7.69%), which needs to be investigated, but indicates that SNBR had better years and this may not be a problem.
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROIC 3.59%
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
SNBR Yearly ROA, ROE, ROICSNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

1.3 Margins

The Operating Margin of SNBR (1.35%) is comparable to the rest of the industry.
SNBR's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 60.05%, SNBR belongs to the best of the industry, outperforming 89.34% of the companies in the same industry.
SNBR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.35%
PM (TTM) N/A
GM 60.05%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
SNBR Yearly Profit, Operating, Gross MarginsSNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

SNBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SNBR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SNBR has been reduced compared to 5 years ago.
Compared to 1 year ago, SNBR has a worse debt to assets ratio.
SNBR Yearly Shares OutstandingSNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SNBR Yearly Total Debt VS Total AssetsSNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

SNBR has an Altman-Z score of -0.10. This is a bad value and indicates that SNBR is not financially healthy and even has some risk of bankruptcy.
SNBR's Altman-Z score of -0.10 is on the low side compared to the rest of the industry. SNBR is outperformed by 78.69% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.1
ROIC/WACC0.4
WACC8.96%
SNBR Yearly LT Debt VS Equity VS FCFSNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

A Current Ratio of 0.19 indicates that SNBR may have some problems paying its short term obligations.
The Current ratio of SNBR (0.19) is worse than 98.36% of its industry peers.
SNBR has a Quick Ratio of 0.19. This is a bad value and indicates that SNBR is not financially healthy enough and could expect problems in meeting its short term obligations.
SNBR has a Quick ratio of 0.09. This is amonst the worse of the industry: SNBR underperforms 95.90% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.09
SNBR Yearly Current Assets VS Current LiabilitesSNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

The earnings per share for SNBR have decreased strongly by -88.40% in the last year.
SNBR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.95%.
The Revenue has been decreasing by -0.19% on average over the past years.
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%

3.2 Future

The Earnings Per Share is expected to grow by 34.93% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -3.38% on average over the next years.
EPS Next Y-326.89%
EPS Next 2Y20.31%
EPS Next 3Y40.55%
EPS Next 5Y34.93%
Revenue Next Year-17%
Revenue Next 2Y-9.86%
Revenue Next 3Y-4.18%
Revenue Next 5Y-3.38%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNBR Yearly Revenue VS EstimatesSNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
SNBR Yearly EPS VS EstimatesSNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNBR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNBR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNBR Price Earnings VS Forward Price EarningsSNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SNBR indicates a rather cheap valuation: SNBR is cheaper than 96.72% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.44
SNBR Per share dataSNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as SNBR's earnings are expected to grow with 40.55% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.31%
EPS Next 3Y40.55%

0

5. Dividend

5.1 Amount

SNBR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SLEEP NUMBER CORP

NASDAQ:SNBR (12/18/2025, 8:00:02 PM)

After market: 8.28 -0.14 (-1.66%)

8.42

-0.04 (-0.47%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners90.49%
Inst Owner Change9.11%
Ins Owners6.39%
Ins Owner Change2.48%
Market Cap191.89M
Revenue(TTM)1.44B
Net Income(TTM)-78.11M
Analysts48.89
Price Target5.61 (-33.37%)
Short Float %35.37%
Short Ratio7.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-915.82%
Min EPS beat(2)-937.57%
Max EPS beat(2)-894.07%
EPS beat(4)1
Avg EPS beat(4)-818.76%
Min EPS beat(4)-1452.29%
Max EPS beat(4)8.9%
EPS beat(8)3
Avg EPS beat(8)-410.77%
EPS beat(12)5
Avg EPS beat(12)-256.42%
EPS beat(16)7
Avg EPS beat(16)-175.27%
Revenue beat(2)0
Avg Revenue beat(2)-8.66%
Min Revenue beat(2)-10.05%
Max Revenue beat(2)-7.26%
Revenue beat(4)0
Avg Revenue beat(4)-6.41%
Min Revenue beat(4)-10.05%
Max Revenue beat(4)-3.11%
Revenue beat(8)1
Avg Revenue beat(8)-4.76%
Revenue beat(12)1
Avg Revenue beat(12)-4.74%
Revenue beat(16)3
Avg Revenue beat(16)-4.59%
PT rev (1m)-26.67%
PT rev (3m)-26.67%
EPS NQ rev (1m)-2716.67%
EPS NQ rev (3m)-303.9%
EPS NY rev (1m)-307.94%
EPS NY rev (3m)-315.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.44%
Revenue NY rev (1m)-2.38%
Revenue NY rev (3m)-2.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 2.44
EPS(TTM)-3.41
EYN/A
EPS(NY)-0.5
Fwd EYN/A
FCF(TTM)-2.06
FCFYN/A
OCF(TTM)-1.27
OCFYN/A
SpS63.22
BVpS-22.88
TBVpS-25.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.42%
ROE N/A
ROCE -13.07%
ROIC 3.59%
ROICexc 3.6%
ROICexgc 4.25%
OM 1.35%
PM (TTM) N/A
GM 60.05%
FCFM N/A
ROA(3y)-0.04%
ROA(5y)6.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.69%
ROIC(5y)19.87%
ROICexc(3y)7.72%
ROICexc(5y)20.02%
ROICexgc(3y)8.92%
ROICexgc(5y)24.22%
ROCE(3y)152.05%
ROCE(5y)421.6%
ROICexgc growth 3Y-45.92%
ROICexgc growth 5Y-20.82%
ROICexc growth 3Y-44.92%
ROICexc growth 5Y-20.21%
OM growth 3Y-34.99%
OM growth 5Y-18.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.42%
GM growth 5Y-0.76%
F-Score4
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.42
Cap/Depr 31.01%
Cap/Sales 1.26%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.09
Altman-Z -0.1
F-Score4
WACC8.96%
ROIC/WACC0.4
Cap/Depr(3y)71.87%
Cap/Depr(5y)77.97%
Cap/Sales(3y)2.57%
Cap/Sales(5y)2.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1135.71%
EPS Next Y-326.89%
EPS Next 2Y20.31%
EPS Next 3Y40.55%
EPS Next 5Y34.93%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y-8.34%
Revenue growth 5Y-0.19%
Sales Q2Q%-19.63%
Revenue Next Year-17%
Revenue Next 2Y-9.86%
Revenue Next 3Y-4.18%
Revenue Next 5Y-3.38%
EBIT growth 1Y-36.2%
EBIT growth 3Y-40.41%
EBIT growth 5Y-18.25%
EBIT Next Year164.29%
EBIT Next 3Y59.7%
EBIT Next 5Y36.4%
FCF growth 1Y38.86%
FCF growth 3Y-75.01%
FCF growth 5Y-51.09%
OCF growth 1Y-136.39%
OCF growth 3Y-55.11%
OCF growth 5Y-32.18%

SLEEP NUMBER CORP / SNBR FAQ

What is the fundamental rating for SNBR stock?

ChartMill assigns a fundamental rating of 1 / 10 to SNBR.


Can you provide the valuation status for SLEEP NUMBER CORP?

ChartMill assigns a valuation rating of 2 / 10 to SLEEP NUMBER CORP (SNBR). This can be considered as Overvalued.


What is the profitability of SNBR stock?

SLEEP NUMBER CORP (SNBR) has a profitability rating of 3 / 10.


How financially healthy is SLEEP NUMBER CORP?

The financial health rating of SLEEP NUMBER CORP (SNBR) is 0 / 10.